| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,986 | 32,769 | 30,147 | 28,072 | | Cost of Revenue | 9,478 | 10,685 | 10,485 | 11,518 | | | Gross Profit |
-
| 22,084 | 19,662 | 16,554 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,467 | 17,504 | 14,020 | 12,828 | | Non Recurring | (308) | 308 |
-
| (415) | | Others | 4,500 | 7,200 | 9,600 | 14,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (2,928) | (3,958) | (10,559) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,849 | (2,928) | (3,958) | (10,559) | | Interest Expense | 1,797 | 1,972 | 1,852 | 2,111 | | Income Before Tax | 52 | (4,900) | (5,810) | (12,670) | | Income Tax Expense | (346) | (2,095) | (2,434) | (5,101) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 398 | (2,805) | (3,376) | (7,569) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 398 | (2,805) | (3,376) | (7,569) | | Preferred Stock And Other Adjustments | (823) | (823) | (823) | (106) | | | Net Income Applicable To Common Shares | ($425) | ($3,628) | ($4,199) | ($7,675) |
|
0.51% Nasdaq 
Income Statement
